Quick Summary

Pine bark, specifically standardized extracts such as Pycnogenol derived from Pinus pinaster, has been studied for multiple potential health effects including antioxidant, anti-inflammatory, cardiometabolic support, neuroprotective, and erectile dysfunction benefits. Clinical evidence supports some effects on cardiometabolic risk factors, cognitive function in mild cognitive impairment, and improvements in erectile dysfunction when used in combination with L-arginine. Safety data from clinical studies suggest good tolerability with minimal reported adverse effects, though data on drug interactions and use in pregnancy or breastfeeding are limited and not well established.

What Is It

Pine bark extract is derived from the bark of the maritime pine tree, Pinus pinaster. The standardized extract known as Pycnogenol is commonly used in supplements. It contains various bioactive compounds including polyphenols and phytosterols, which are believed to contribute to its biological activities.

Traditional Uses

Traditionally, pine bark extract has been used in herbal medicine for its antioxidant properties and support of vascular and circulatory health. It has also been employed in various cultures for general wellness and inflammatory conditions.

Active Compounds

  • Polyphenolic compounds (including procyanidins and flavonoids)
  • Phytosterols (notably β-sitosterol)
  • Other bioactive constituents with antioxidant and anti-inflammatory properties

Potential Benefits with Evidence Levels

  • Erectile Dysfunction (Moderate evidence): Combination of Pycnogenol and L-arginine has shown significant improvements in erectile function domains in patients with mild to moderate erectile dysfunction based on a meta-analysis of randomized controlled trials (3 RCTs, 184 patients).
  • Mild Cognitive Impairment (Moderate evidence): Pycnogenol demonstrated the highest probability of improving cognitive function and daily living scores among botanical interventions in a systematic review and network meta-analysis of 19 randomized trials involving 4956 participants.
  • Cardiometabolic Risk Factors (Moderate evidence): Supplementation with pine bark extract significantly reduced systolic and diastolic blood pressure, fasting blood sugar, hemoglobin A1c, body weight, and LDL cholesterol levels versus controls in a meta-analysis of 27 randomized controlled trials with 1685 participants.
  • Antioxidant and Anti-Inflammatory Effects (Preclinical and Limited Clinical evidence): Pycnogenol exhibits antioxidant, anti-inflammatory, immunomodulatory, and antiviral properties associated with polyphenolic compounds, demonstrated in preclinical studies and some human research, suggesting potential therapeutic applications pending further clinical validation.
  • Benign Prostatic Hyperplasia (BPH) (Low to Moderate evidence): Phytosterols from pine bark (mainly β-sitosterol) inhibited prostate smooth muscle contraction and stromal cell growth in ex vivo human studies, indicating a possible role in managing lower urinary tract symptoms (LUTS); however, large randomized controlled trials are lacking.
  • Pediatric Mental Health (ADHD) (Limited/Insufficient evidence): Limited clinical evidence exists for pine bark extract in pediatric ADHD, with insufficient data to support efficacy claims.

Side Effects

Pine bark extract (e.g., Pycnogenol) is generally well tolerated in clinical trials. Mild gastrointestinal symptoms, such as stomach upset, have been reported especially when combined with L-arginine. No serious adverse events have been consistently reported in reviewed studies.

Drug Interactions

Drug interactions with pine bark extract are not well characterized due to insufficient evidence. Caution is advised when combining with other medications, and consultation with a healthcare provider is recommended.

Who Should Avoid It

  • Pregnant or breastfeeding women, as safety has not been established in these populations.
  • Individuals with known allergies to pine or related compounds.
  • People on concurrent medications should consult their healthcare provider due to limited interaction data.

Evidence Limitations

  • Many clinical trials are small or short-term, limiting generalizability and the assessment of long-term safety and efficacy.
  • Significant heterogeneity exists among study populations, extract formulations, and dosing protocols.
  • Limited high-quality randomized controlled trials isolate pine bark extract’s effects apart from combination products like Pycnogenol and L-arginine.
  • Data on drug interactions, contraindications, and use during pregnancy or breastfeeding are sparse.
  • Preclinical findings require further clinical validation to support therapeutic claims conclusively.

References

Last Reviewed

June 2024

Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before using herbal supplements, especially if you have existing health conditions or are taking medications. The safety and efficacy of pine bark extract for various conditions are still under investigation, and its use should be approached with caution.